M
Maxim A. Vodyanik
Researcher at University of Wisconsin-Madison
Publications - 34
Citations - 16911
Maxim A. Vodyanik is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Cellular differentiation & Embryonic stem cell. The author has an hindex of 20, co-authored 32 publications receiving 16164 citations.
Papers
More filters
Journal ArticleDOI
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Junying Yu,Maxim A. Vodyanik,Kim Smuga-Otto,Jessica Antosiewicz-Bourget,Jennifer L. Frane,Shulan Tian,Jeff Nie,Gudrun A. Jonsdottir,Victor Ruotti,Ron Stewart,Igor I. Slukvin,James A. Thomson +11 more
TL;DR: This article showed that OCT4, SOX2, NANOG, and LIN28 factors are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells.
Supporting Online Material for Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Junying Yu,Maxim A. Vodyanik,Kim Smuga-Otto,Jessica Antosiewicz-Bourget,Jennifer L. Frane,Shulan Tian,Jeff Nie,Gudrun A. Jonsdottir,Victor Ruotti,Ron M. Stewart,Igor I. Slukvin,James A. Thomson +11 more
TL;DR: Yu et al. as discussed by the authors proposed online material for induced pluripotent stem cell lines derived from human Somatic Cells, which can be used for transplanting human stem cells to humans.
Journal ArticleDOI
Human embryonic stem cell-derived CD34+ cells : efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential
TL;DR: Data indicate that CD34+ cells generated through hES/OP9 coculture display several features of definitive hematopoietic stem cells.
Journal ArticleDOI
Hematopoietic and endothelial differentiation of human induced pluripotent stem cells.
Kyung Dal Choi,Junying Yu,Kim Smuga-Otto,Giorgia Salvagiotto,William M. Rehrauer,Maxim A. Vodyanik,James A. Thomson,Igor I. Slukvin +7 more
TL;DR: Although several issues remain to be resolved before iPSC‐derived blood cells can be administered to humans for therapeutic purposes, patient‐specific iPSCs can already be used for characterization of mechanisms of blood diseases and for identification of molecules that can correct affected genetic networks.
Journal ArticleDOI
Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures
TL;DR: It is demonstrated that early progenitors committed to hematopoietic development could be identified by surface expression of leukosialin (CD43) and it was demonstrated that the first-appearing CD34(+)CD43(-)CD235a(+) CD41a(+/-)CD45(-) cells represent precommitted erythro-megakaryocytic progenitor.